Premium Nahrungsergänzungsmittel | artgerecht

Acetylation Test – Definition and Clinical Significance

The acetylation test is a diagnostic procedure used to determine a person´s individual acetylation status, revealing how quickly the body breaks down certain substances and medications.

Regular tips about health Regular tips about health

Things worth knowing about "Acetylation Test"

The acetylation test is a diagnostic procedure used to determine a person´s individual acetylation status, revealing how quickly the body breaks down certain substances and medications.

What Is the Acetylation Test?

The acetylation test is a diagnostic procedure used in pharmacogenetics and environmental medicine. Its purpose is to determine an individual´s acetylation status – specifically, the activity of the enzyme N-acetyltransferase (NAT), particularly the NAT2 isoform found in the liver. This enzyme plays a central role in the metabolism of numerous drugs and foreign substances (xenobiotics) through a process known as acetylation.

Acetylation is a biochemical reaction in which an acetyl group is added to a substrate molecule. This process is crucial for the detoxification and elimination of many pharmaceuticals, food additives, and environmental pollutants.

Fast and Slow Acetylators

Based on the test result, individuals are generally classified into two main groups:

Fast acetylators (rapid acetylators): NAT2 enzyme activity is high. Certain medications are broken down more quickly, which may reduce their therapeutic effect or duration. In some cases, potentially harmful metabolites may also be produced more rapidly.
Slow acetylators: Enzyme activity is reduced. Medications remain in the body longer, which can lead to enhanced therapeutic effects but also an increased risk of adverse side effects.

Some classifications also include an intermediate group with moderate acetylation capacity.

How the Test Is Performed

The acetylation test is typically conducted as a urine test or blood test. Commonly used test substances include caffeine or sulfamethazine. After ingesting a defined amount of the test substance, the concentrations of the parent compound and its metabolites are measured in blood or urine. From this ratio, the enzyme activity can be calculated.

Alternatively, acetylation status can be determined through genotyping (DNA analysis), in which specific variants of the NAT2 gene are examined. This molecular genetic approach is increasingly preferred as it provides direct and precise information about a person's genetic makeup.

Clinical Significance and Applications

The acetylation test has relevance across several medical areas:

Drug therapy: For certain medications such as isoniazid (used to treat tuberculosis), hydralazine, procainamide, and some sulfonamides, acetylation status is critical for dosing and risk of side effects. Slow acetylators face a higher risk of adverse drug reactions with these substances.
Environmental medicine: Acetylation status influences how the body responds to certain environmental pollutants, particularly aromatic amines. Slow acetylators may face an elevated risk of certain occupational diseases.
Cancer risk research: Studies have examined the relationship between acetylation status and the risk of specific cancers, especially bladder cancer and colorectal cancer.
Food intolerances: In environmental and nutritional medicine, the test is occasionally used to better understand intolerances to certain food additives such as benzoates or colorants.

Interpretation and Limitations

The results of the acetylation test should always be interpreted by a qualified healthcare professional. Acetylation status is genetically determined and remains largely constant throughout a person's life, although it may be influenced by liver disease or certain medications.

It is important to note that the acetylation test alone does not provide a diagnosis. Rather, it is a tool to understand individual differences in drug metabolism and to tailor therapies accordingly.

References

Hein D.W. et al. - Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiology, Biomarkers and Prevention, 2000.
World Health Organization (WHO) - Pharmacogenomics: ethical issues. WHO Report, 2007. Available at: https://www.who.int
Cascorbi I. - Pharmacogenetics: inherited resistance and altered drug metabolism. Deutsches Arzteblatt International, 2003.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.